Hae-Jin Kim

24PUBLICATIONS
74CO-AUTHORS
TransgenesisTraditional Chinese medicine and treatmentsPharmacogenomicsMolecular targetsNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 15, 2026
Enavogliflozin Improves Non-invasive Hepatic Steatosis Indices in Patients With Type 2 Diabetes: A Pooled Analysis of Three Randomised Trials.

|May 25, 2026
Highlights of the 2026 Korean Society of Hypertension guidelines for the management of hypertension: what's new and what has changed.

|Dec 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial.

Seung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong

|Oct 15, 2025
Is the next STEP on the BPROAD to intensive blood pressure lowering for all type 2 diabetic patients?: consensus statements from the Korean Society of Hypertension.

Eun Mi Lee, In-Jeong Cho, Hae Jin Kim

|Jun 25, 2025
EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study).

Ji Eun Jun, Sung Hee Choi, Min Kyong Moon

|May 14, 2025
Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yu Jung Heo, Jieun Park, Nami Lee

Pageof 4

Frequent Collaborators

7 joint publications

Dae-Jung Kim

7 joint publications

Seung-Jin Han

5 joint publications

Kwan-Woo Lee

5 joint publications

In-Kyung Jeong